People who begin obesity treatment with glucagon-like peptide-1 receptor agonists (GLP-1s) and then undergo metabolic and ...
People who begin obesity treatment with glucagon-like peptide-1 receptor agonists (GLP-1s) and then undergo metabolic and ...
The number of metabolic and bariatric surgery procedures in the United States dropped below 200,000 in 2024 for the first ...
India Today on MSN
Weight-loss drug boom shakes bariatric surgery in US: Is India next?
Bariatric surgeries have fallen sharply in the US as GLP-1 weight-loss drugs have gained ground. In India, doctors say the ...
A new real-world analysis of more than 90,000 patients with obesity and type 2 diabetes finds metabolic and bariatric surgery ...
Fewer than 1% of people eligible for weight-loss surgery now get it in any given year, according to the ASMBS. Researchers ...
A long-term study found bariatric surgery patients faced higher risks of iron, vitamin B12 and folic acid deficiencies years ...
The number of bariatric surgeries performed annually in the U.S. has taken a sharp drop lately, new research shows, ...
People who begin obesity treatment with glucagon-like peptide-1 receptor agonists (GLP-1s) and then undergo metabolic and ...
The number of metabolic and bariatric surgery procedures in the United States dropped below 200,000 in 2024 for the first ...
Metabolic and bariatric surgery associated with significantly greater weight loss and higher rates of obesity-related disease remission than glucagon-like peptide-1 receptor agonists (GLP-1s), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results